GE Healthcare

433 articles about GE Healthcare

• GE Healthcare Introduces SIGNA Experience: A New Platform of Transformative Technologies that Leverage the Power of AI and Deep-Learning in MRI Scanning

  11/27/2022

  GE Healthcare announced the launch of SIGNA Experience, a platform of four synergistic technologies that help users through the diagnostic journey.

• GE Healthcare Highlights Transformative Precision Innovations and Collaborations that Help Drive the Future of Health

  11/27/2022

  Ahead of its planned spinoff from GE the first week of January 2023, GE Healthcare reveals over 40 solutions that aim to improve patient outcomes and increase healthcare efficiency at the Radiological Society of North America’s 2022 Annual Meeting.

• GE Healthcare Imaging Solutions Increase Workflow Efficiency and Optimize Radiologists’ Time to Help Reduce Burnout

  11/22/2022

  As radiology departments face challenges in a new era of healthcare, GE Healthcare imaging solutions are designed to support clinicians in meeting competing demands for their time and enable greater focus on patient care.

• GE Healthcare Announces $80 Million Investment To Expand Contrast Media Production Capacity

  11/17/2022

  GE Healthcare’s Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30 percent at its Active Pharmaceutical Ingredients site in Lindesnes, Norway.

• GE Healthcare and Accuray Collaborate to Expand Access, Advance the Practice of Precision Radiation Therapy

  10/21/2022

  GE Healthcare and Accuray Incorporated announced that they have signed a global commercial collaboration agreement designed to provide solutions that make it possible for more healthcare teams around the world to tailor patients' care at every stage of their treatment journey.

• GE Healthcare Tops List with Highest Number of AI-Enabled Device Authorizations, More Than Any Other Medical Technology Company

  10/20/2022

  On a recently updated FDA list of artificial intelligence (AI) enabled medical devices, GE Healthcare had the highest number of authorizations, with 42 listed 510(k) clearances to date, in the United States.

• GE Healthcare and AMC Health to Partner in Remote Patient Monitoring to Provide Patients with Chronic and Post-Acute Care in the Home

  10/19/2022

  GE Healthcare and AMC Health today announced a collaboration that allows clinicians to offer Remote Patient Monitoring (RPM) as a virtual care solution that extends patient care outside the hospital to the home environment.

• GE Healthcare Announces Collaboration to Advance Digital Transformation of Pathology

  10/18/2022

  GE Healthcare and Tribun Health have entered a collaboration with the intent to provide digital pathology departmental solutions that give healthcare providers a more holistic view of patient records.

• GE Healthcare Introduces Omni Legend: A First-of-its-Kind All-Digital PET/CT System to Drive Efficiency, Enhance Diagnostics, and Deliver on Precision Medicine

  10/16/2022

  At the European Association of Nuclear Medicine Annual Meeting, GE Healthcare proudly introduces Omni Legendi, the first system on its all-new, all-digital PET/CT platform.

• 

  FDA Review: Amylyx, Sarepta, Sanofi-Regeneron and More

  9/30/2022

  The FDA had a busy week, approving drugs, greenlighting clinical trials and other regulatory activities for Immuneering, Amylyx, Sarepta, Sanofi, and Regeneron and more. 

• GE Healthcare and Lantheus Phase III Clinical Trial Finds [18F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease

  9/13/2022

  GE Healthcare and Lantheus Phase III Clinical Trial Finds [ 18 F]flurpiridaz PET Radiotracer Could Improve Detection of Coronary Artery Disease.

• Healthcare Is Personal: GE Healthcare’s Total Molecular Imaging Solutions Enable Precision Health & Theranostics for Personalized Prostate Cancer Care

  6/9/2022

  GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics to help improve patient outcomes across care areas, including prostate cancer – the most prevalent cancer in men and the third most prevalent cancer overalli.

• GE Healthcare Advances the Future of Precision Medicine in Oncology with New Technology Partners at #ASCO22

  6/3/2022

  From early detection to remote monitoring and data sharing, GE Healthcare’s innovative suite of diagnostic and treatment technologies are designed to help improve detection, clinical efficiency, operational efficiency, and outcomes for cancer patients.

• GE Healthcare, Medtronic Partnership Accelerates Global Access to Personalized Care by Delivering Advanced Patient Monitoring Solutions on the CARESCAPE Platform

  6/1/2022

  Clinicians now have added ability to personalize care with the integration of two continuous monitoring solutions from Medtronic plc – Microstream™ capnography and INVOS™ regional oximetry technology for perioperative and ICU care on the GE Healthcare CARESCAPE precision monitoring platform.

• GE Healthcare Enters Homecare Segment With Strategic Investment in Pulsenmore, Aims to Increase Peace of Mind for Expectant Mothers and Reduce In-Person Visits

  5/12/2022

  GE Healthcare has entered into an agreement to invest up to $50 million in Israeli start-up Pulsenmore, marking another strategic step forward in enabling precision health.

• RaySearch collaborates with GE Healthcare to improve radiation oncology treatment planning

  5/9/2022

  RaySearch Laboratories AB is proud to announce an agreement to collaborate with GE Healthcare, a leading global medical technology, diagnostics, and digital solutions company, to develop a new radiation therapy simulation and treatment planning workflow solution, designed to make use of the latest advancements in treatment planning technology.

• A Bold New World: GE Healthcare’s Pioneering Deep Learning Image Reconstruction Technology Benefits More Than 2 Million Patients Globally

  5/6/2022

  At the International Society for Magnetic Resonance in Medicine 2022 Annual Meeting, GE Healthcare boasts the continued expansion of its pioneering deep learning image reconstruction solution, AIR Recon DL, to its tens of thousands of install base customers as an upgrade as well as with new purchases across its MR product portfolio.

• Medtronic and GE Healthcare announce a collaboration to meet growing need for outpatient care

  4/28/2022

  Providing excellent care inside and outside of the traditional hospital is the new normal for patients, clinicians, and payers seeking more choices without compromising excellent outcomes.

• GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Care

  4/28/2022

  Providing excellent care inside and outside of the traditional hospital is the new normal for patients, clinicians, and payers seeking more choices without compromising excellent outcomes.

• GE Healthcare Announces First Patient Dosed in Phase III Clinical Trial for New Dopamine Transporter Imaging Radiopharmaceutical

  3/28/2022

  GE Healthcare has announced the first patient dosed in the Phase III clinical trial for a Positron Emission Tomography radiopharmaceutical imaging agent which aims to assist in the evaluation of adult patients with suspected Parkinsonian syndromes, support research and improve patient care.